Abstract
Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who are undergoing an elective invasive procedure.
Lingua originale | English |
---|---|
pagine (da-a) | 716-724 |
Numero di pagine | 9 |
Rivista | THE NEW ENGLAND JOURNAL OF MEDICINE |
Volume | 367 |
DOI | |
Stato di pubblicazione | Pubblicato - 2012 |
Keywords
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Benzoic Acids
- Chronic Disease
- Double-Blind Method
- Female
- Hemorrhage
- Humans
- Hydrazines
- Liver Cirrhosis
- Male
- Middle Aged
- Platelet Count
- Platelet Transfusion
- Pyrazoles
- Receptors, Thrombopoietin
- Surgical Procedures, Elective
- Thrombocytopenia
- Young Adult